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Translation elongation factor 1Bβ (eEF1Bβ) is a metazoan-specific protein catalyzing the guanine nucleotide 
exchange on translation elongation factor 1A (eEF1A). eEF1Bβ was reported to form oligomers. Aim. To 
define the structural region of human eEF1Bβ that mediates its self-association. In addition, the various trun-
cated forms of this protein were tested in the guanine nucleotide exchange assay with two isoforms of mam-
malian eEF1A. Methods. The truncated forms of eEF1Bβ were generated by PCR, cloned, expressed in 
Escherichia coli and purified to homogeneity. Their apparent molecular masses were determined by analytical 
gel filtration and their guanine nucleotide exchange activities were assessed by filter binding assay. Results. 
Complete deletion of the N-terminal domain of eEF1Bβ does not affect its oligomerization propensity while 
deletion of the leucine-zipper motif drastically decreases the apparent molecular mass of the truncated form 
compared to the full-length protein. Also, the leucine-zipper motif of eEF1Bβ fused to glutathione S-transferase 
causes oligomerization of the chimeric protein. It was demonstrated that all N-terminally truncated forms of 
eEF1Bβ displayed similar catalytic activity to that of the full-length protein. Weak inhibitory effect on the 
catalytic activity was observed only for the truncated form with partially deleted central acidic region. 
Conclusions. The leucine-zipper motif facilitates oligomerization of recombinant eEF1Bβ. Stepwise deletion 
of the eEF1Bβ N-terminal domain does not significantly affect the guanine nucleotide exchange activity of the 
truncated proteins. 
K e y w o r d s: translation elongation factor 1, guanine nucleotide exchange, protein structural domains. 
Introduction
Guanine-nucleotide exchange factors (GEFs) play 
an important role during the elongation cycle of pro-
tein biosynthesis in eukaryotes catalyzing the GDP/
GTP exchange on translation elongation factor 1A 
(eEF1A) and, thus, restoring its active GTP bound 
conformation. In turn, the eEF1A*GTP molecules 
form the complexes with various aminoacylated 
tRNAs and deliver them to the ribosome ensuring 
the process of protein biosynthesis [1]. In mammals, 
there are two isoforms of eEF1A (designated 
eEF1A1 and eEF1A2) that share 97 % amino acid 
homology but are encoded by different genes [2]. 
Both eEF1A1 and eEF1A2 have different non-ca-
nonical functions, but their role in translation is be-
lieved to be identical [2–4].
In higher eukaryotes, GEFs that participate in 
translation elongation are organized in a stable macro-
molecular complex, eEF1B, containing three subunits 
designated eEF1Bα, eEF1Bβ and eEF1Bγ. We use the 
unifying nomenclature proposed by Merrick [5]. Both 
eEF1Bα and eEF1Bβ catalyze the GDP/GTP ex-
change on eEF1A, while a functional role of eEF1Bγ 
is still poorly understood [3]. eEF1Bγ may be consi-
dered as a scaffold component of the eEF1B complex 
since it contains the binding sites for both eEF1Bα 
and eEF1Bβ [6–8]. It has been reported that eEF1Bγ 
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binding enhances the activity of eEF1Bα but not 
eEF1Bβ [7]. Recently, we have shown that the 
N-terminal domain negatively influences the catalytic 
activity of full-length eEF1Bα. Deletion of the 
eEF1Bα N-terminal domain as well as formation of a 
tight complex with the eEF1Bγ N-terminal domain 
eliminated this inhibitory effect [9]. 
eEF1Bβ is a guanine-nucleotide exchange factor 
specific for metazoans. Its C-terminal domain is 
highly homologous to the C-terminal domain of 
eEF1Bα that is responsible for guanine nucleotide 
exchange activity [7, 10]. Recently, the structure of 
human eEF1Bβ C-terminal fragment (residues 153–
281), comprising a central acidic region (termed the 
CAR domain) and the GEF domain, was solved by 
NMR. Both human eEF1Bα and eEF1Bβ GEF do-
mains superimpose with an RMSD of 1.6Å, reveal-
ing a highly conserved overall fold [11]. The CAR 
domain was described as a new structural element of 
eEF1Bβ that binds translationally controlled tumor 
protein (TCTP) [12]. The CAR domain is conserved 
in all eEF1B guanine nucleotide exchange factors 
and is structurally independent from the GEF do-
main [11]. The less conserved N-terminal domain of 
eEF1Bβ interacts with the N-terminal part of eEF1Bγ 
[7, 8, 13] and the N-terminus of valyl-tRNA synthe-
tase (ValRS) [7]. Another specific feature of eEF1Bβ 
is the presence of relatively long leucine-zipper mo-
tif that was suggested to be involved in the eEF1Bβ 
self-association [7, 14, 15]. Mansilla and co-workers 
demonstrated the direct interaction between eEF1Bβ 
molecules using yeast two-hybrid system [13]. 
However, the eEF1Bβ N-terminal fragment includ-
ing the leucine-zipper motive was, surprisingly, not 
sufficient to sustain its self-association [13]. Thus, 
the oligomeric structure of eEF1Bβ and domain fa-
cilitating its self-association is still unidentified. 
In this study, we attempted to delineate the struc-
tural region of human eEF1Bβ responsible for its 
self-association. For this purpose, several truncated 
forms of the protein were designed, purified to ho-
mogeneity and characterized by size-exclusion chro-
matography. In order to determine the significance 
of the eEF1Bβ N-terminal domain and the leucine-
zipper motif for the catalytic activity of the GEF do-
main, the rate of GDP/GDP exchange on eEF1A1 
and eEF1A2 in the presence of all eEF1Bβ 
N-terminally truncated forms were measured and 
compared to that of the full-length protein. 
Materials and Methods
The conservative domains in the primary structure 
of eEF1Bβ were defined by multiple sequences 
alignment using CLUSTAL W [16]. The following 
eEF1Bβ amino acid sequences from Genbank data-
base were used: Homo sapiens, NCBI reference se-
quence NP_001951.2; Mus musculus, GenBank ac-
cession number AAG17466.1; Xenopus laevis, 
NCBI reference sequence NP_001081523.1; 
Drosophila melanogaster, GenBank accession num-
ber Q9VL18.1; Bombyx mori, GenBank accession 
number BAB21109.1; Hydra vulgaris, NCBI refer-
ence sequence XP_002156180.1; Salmo salar, 
GenBank accession number ACN12466.1; Caligus 
clemensi, GenBank accession number ACO15230.1.
Plasmid construction
The cDNA fragments encoding the N-terminally 
truncated forms of human eEF1Bβ were produced 
by PCR using forward primers (as listed below) con-
taining EcoRI restriction site and the reverse primer 
5’- TTCTCGAGTCAAATCTTGTTGAAAGCTGC 
TATATCTACACTCT, containing an XhoI restric-
tion site. The forward primer for the eEF1Bβ(43-281) 
fragment was 5’-AAGAATTCGCCAGCGTGATC 
CTCCGTGACATT, that for eEF1Bβ(78–281) was 
5’-TTGAATTCGGTGAACTCGTCGTTCGTAT 
TGCCA, that for eEF1Bβ(117–281) was 5’-AAGA 
ATTCAAGAGTTCGCCTGGACACCGAGCCA, 
that for eEF1Bβ(136-281) was 5’-AAAGAATTC 
ATGCGCCAAGTGGAGCCCCCA and that for 
eEF1Bβ(183-281) – 5’-AAAGAATTCGCGGAGA 
AGAAGGCCAAGAA. 
The cDNA encoding the leucine-zipper motif of 
eEF1Bβ comprising the residues 78-118 was ampli-
fied using the forward primer 5’-TTGAATTCGGTGA 
ACTCGTCGTTCGTATTGCCA and the reverse pri-
mer 5’-AAACTCGAGGCTCTTCTCCAGCACGT, 
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containing an EcoRI and an XhoI restriction sites, re-
spectively. PCR was performed with DreamTaq DNA 
Polymerase (Thermo Fisher Scientific, USA) using 
as a template pGEX6P-1/eEF1Bβ plasmid encoding 
full-length human eEF1Bβ [17]. The PCR pro-ducts 
were purified and digested by XhoI and EcoRI 
(Thermo Fisher Scientific, USA), and ligated into 
pGEX6P-1 (GE Healthcare, UK) expression vector 
digested by the same enzymes. All obtained con-
structs were verified by sequencing. The resulting 
recombinant plasmids encoded the truncated forms 
of eEF1Bβ in-frame with the GST sequence.
Expression and purification of recombinant 
proteins
Full-length eEF1Bβ, also referred as to eEF1Bβ(FL), 
and its truncated forms were expressed in Escherichia 
coli BL21Gold strain (Stratagene, USA) grown on 
LB medium supplemented with 100 μg/ml ampicil-
lin. All target proteins except for GST-
eEF1Bβ(183–281) and GST-eEF1Bβ(78–118) were 
purified according to the procedure described below. 
The bacterial culture was grown at 37 °C and the 
expression of protein was induced for 3 hours with 
1 mM isopropyl-β-D-thiogalactopyranoside when 
the absorbance at 600 nm reached 0.5. Then, the 
cells were harvested by centrifugation (3220 g for 
10 min at 4 °C), washed twice (10 min at 4 °C) with 
40 ml of ice-cold extraction buffer containing PBS 
(1.47 mM KH2PO4, 10 mM Na2HPO4, 137 mM 
NaCl, 2.7 mM KCl pH 7,4), 10 % glycerol and 5 mM 
2-mercaptoethanol, followed by centrifugation 
(6000 g for 5 min at 4 °C). The cell pellet was dis-
solved in 8 ml of extraction buffer per 1 mg of cells 
and sonicated. All subsequent steps were performed 
at 4 °C. After centrifugation at 18500 g for 30 min, 
the clear supernatant was recovered. This solution 
was mixed with 4–5 ml of a 50 % slurry of 
Glutathione sepharose™ 4B (GE Healthcare, 
Sweden), pre-equilibrated with the same buffer, and 
incubated on the orbital shaker overnight. The resin 
was washed three times for 20 min in a tube with 
40 ml of the extraction buffer, followed by centrifu-
gation at 3000 g for 5 min. After the last wash 
Glutathione sepharoseTM 4B was packed into a col-
umn and washed extensively to remove unbound 
material. The target protein was stepwise eluted us-
ing 20 mM glutathione, pH 8.0, in the extraction buf-
fer. Fractions were collected and analyzed by SDS-
PAGE. The purest fractions were combined and dia-
lyzed against the cleavage buffer (30 mM Tris-HCl, 
pH7.5, 150 mM NaCl, 10 % glycerol, 5 mM 2-mer-
captoethanol and 0.01 % Tween 20). The GST-tag 
was removed by incubation with PreScission prote-
ase (GE Healthcare, Germany) according to manu-
facturer’s instruction. Then, the protein mixture was 
applied onto a HiTrap Q sepharose (1 ml) column 
(GE Healthcare, Sweden), equilibrated with clea-
vage buffer. The column was washed with 250 mM 
NaCl in buffer containing 30 mM Tris-HCl, pH7.5, 
10 % glycerol, 5 mM 2-mercaptoethanol and 0.01 % 
Tween 20. eEF1Bβ and its N-terminally truncated 
forms were eluted from the column using a 250–
450 mM NaCl gradient in the same buffer. Fractions 
were collected and analyzed by SDS-PAGE. The 
purest fractions were combined and dialyzed against 
the storage buffer (30 mM Tris-HCl, pH7.5, 150 mM 
NaCl, 55 % glycerol and 5 mM 2-mercaptoethanol). 
GST-eEF1Bβ(183–281) was purified on a Gluta-
thione sepharose™ 4B column only, as described 
above. The eEF1Bβ(183–281) fragment precipitated 
after incubation with PreScission protease, and 
therefore, the GST-eEF1Bβ(183–281) fusion protein 
was used for the experiments. The purest fractions of 
the fusion protein after а Glutathione sepharoseTM 
4B column were combined and dialyzed against the 
storage buffer. 
GST-eEF1Bβ(78–118) was purified on a Glutathione 
sepharose™ 4B column, as described above. Then, the 
purest and most concentrated fractions were combined 
and applied onto a HiLoad 16/600 Superdex 200 per 
grade (16 × 600 mm, 120 ml) column (GE Healthcare, 
Sweden), equilibrated with buffer containing 25 mM 
Tris-HCl, pH7.5, 150 mM NaCl, 5 % glycerol and 
5 mM 2-mercaptoethanol. Fractions were collected 
and analyzed by SDS-PAGE. The purest fractions of 
the major protein peak were combined and dialyzed 
against the storage buffer. 
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The proteins were stored at – 20 °C. The protein con-
centrations were determined using the following calcu-
lated absorption coefficients (A280 units·mg-1·cm2): 
0.72 for eEF1Bβ(FL), 0.52 for eEF1Bβ(43–281), 0.60 
for eEF1Bβ(78–281), 0.74 for eEF1Bβ(117–281), 0.81 
for eEF1Bβ(136–281), 1.46 for GST-eEF1Bβ(183–281) 
and 1.36 for GST-eEF1Bβ (78–118). 
Analytical gel filtration of proteins
Analytical gel filtration of all the purified proteins was 
performed on a Superose 6 HR 10/30 (24 ml) column 
(GE Healthcare, Sweden). The column was equili-
brated with 25 mM imidazole HCl, pH 7.5, 150 mM 
NaCl, 5 % glycerol, 5 mM 2-mercaptoethanol. The 
sample (0.1 ml) was loaded onto the column and elut-
ed at a flow rate of 0.4 ml/min. The column calibra-
tion and molecular mass determination of the protein 
of interest have been described previously [18]. 
Preparation of the eEF1Bβγ complex
Human recombinant eEF1Bγ was purified as de-
scribed earlier [18]. For formation of the eEF1Bβγ 
complex, purified eEF1Bγ and eEF1Bβ(FL) were 
mixed in the buffer containing 25 mM imidazole 
HCl, pH 7.5, 150 mM NaCl, 5 % glycerol, 5 mM 
2-mercaptoethanol and incubated during 5 min at 
37 ºC. The final concentration of both eEF1Bγ and 
eEF1Bβ(FL) was 20 µM. Then, the eEF1Bβγ com-
plex was purified on a Superose 6 HR 10/30 column 
(24 ml), equilibrated with the same buffer. The most 
concentrated fractions of the eEF1Bβγ complex 
were combined, dialyzed and concentrated against 
the storage buffer (30 mM Tris-HCl, pH7.5, 150 mM 
NaCl, 55 % glycerol and 5 mM 2-mercaptoethanol), 
and used to measure the rate of guanine nucleotide 
exchange on eEF1A1 and eEF1A2. The protein con-
centration of the eEF1Bβγ complex was determined 
using the calculated molar absorption coefficient 
109820 M–1·cm–1 assuming that the stoichiometry of 
the subunits in the complex is 1:1. 
[3H]GDP/GDP exchange
eEF1A2 and eEF1A1 were purified as previously 
described [19, 20]. The kinetics of guanine nucleo-
tide exchange on eEF1A2 in the absence or presence 
of 4 nM concentration of eEF1Bβ(FL), its truncated 
forms or the eEF1Bβγ complex were performed at 
25 °C as described in detail previously [21]. For 
eEF1A1, the same conditions were used except the 
concentration of exchange factors and the tempera-
ture of reaction. The concentration of eEF1Bβ(FL), 
its truncated forms or the eEF1Bβγ complex was 
20 nM, and the exchange reaction was carried out at 
0 °C. The reaction mixtures contained eEF1A1*[3H]
GDP or eEF1A2*[3H]GDP complexes in a final con-
centration of 692 nM and 150 µM GDP. 
First order rate constants of the GDP/GDP ex-
change reaction in the absence (k–1) and in the pres-
ence (kapp) of exchange factors were obtained by fit-
ting to a single exponential function (y=A1exp(–x/
t1)+y0) using OriginPro 8 software (OriginLab, USA). 
Results and Discussion
Domain structure of eEF1Bβ
By multiple sequence alignment four conservative 
domains can be delineated in the primary structure 
of eEF1Bβ from different species (Fig. 1A): the 
N-terminal domain (residues 1~82) contains highly 
conservative (residues 1~33) and low conservative 
(residues 33~82) regions, the leucine-zipper motive 
(residues 82~124) [14, 15], the central acidic region 
(residues ~165–210) [12] and the C-terminal domain 
(residues ~210–281) responsible for GEF activi-
ty [7]. The leucine-zipper motive and the CAR do-
main are connected by a linker region that possesses 
low homology among the different species. By con-
trast, the leucine-zipper motive is strongly conserved 
(Fig. 1A) implying an important function for this 
structure region. To explore the significance of the 
eEF1Bβ structural domains for its self-association 
and catalytic activity, several truncated forms of hu-
man eEF1Bβ were designed (Fig. 1B). First deletion 
mutant, eEF1Bβ(43–281), lacks the most conserva-
tive part of the N-terminal domain, whereas 
eEF1Bβ(78–281) is deprived of the entire N-terminal 
domain. Then we removed the leucine-zipper motive 
to generate the eEF1Bβ(117–281) deletion form. 
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eEF1Bβ(136–281) and eEF1Bβ(183–281) possess 
partly truncated linker and partly truncated central 
acidic region, respectively. The leucine-zipper mo-
tive comprising amino acids 78–118 fused to GST 
was also used in this study. 
Purification of full-length eEF1Bβ and its trun-
cated forms
Purification of eEF1Bβ(FL) and its several truncated 
forms, except for GST- eEF1Bβ(183–281) and GST-
eEF1Bβ(78–118), was performed by two consecu-
tive Glutathione sepharose™ 4B and HiTrap Q sep-
harose column chromatographies. The GST fusion 
proteins obtained after the first purification step were 
treated by PreScission protease. Further, the target 
proteins were separated from GST on a HiTrap Q 
sepharose column. eEF1Bβ(FL) and its truncated 
forms eEF1Bβ(43–281), eEF1Bβ(78–281), 
eEF1Bβ(117–281) and eEF1Bβ(136–281) bind 
HiTrap Q sepharose at 200 mM NaCl whereas GST 
does not. Finally, highly purified proteins were ob-
tained after their elution from the column by a salt 
Fig. 1. Primary structure of eEF1Bβ. (A) Multiple amino acid 
sequence alignment of eEF1Bβ from various species. Abbrevia-
tions: HS, Homo sapiens; MM, Mus musculus; BM, Bombyx 
mori; DM, Drosophila melanogaster; HV, Hydra vulgaris; XL, 
Xenopus laevis; SS, Salmo salar; CC, Caligus clemensi. 
(B) Schematic representation of the eEF1Bβ truncated forms. 
Abbreviations: LZ, leucine-zipper motif; CAR, central acidic 
region; GEF, guanine nucleotide exchange factor.
A
B
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gradient as jugged by SDS-PAGE (Fig. 2). The yield 
of eEF1Bβ(FL) was ~ 2 mg, that of eEF1Bβ(43–281) 
was ~ 7 mg, eEF1Bβ(78–281) was ~ 5 mg, that of 
eEF1Bβ(117–281) was ~ 5 mg, eEF1Bβ(136–281) 
was ~ 5 mg, per 1 L of BL21Gold bacterial culture. 
GST-eEF1Bβ(183–281) was purified on a Gluta-
thione sepharose™ 4B column only, because treat-
ment with PreScission protease resulted in precipita-
tion of the eEF1Bβ(183–281) fragment. About 
22 mg of GST-eEF1Bβ(183–281) can be obtained 
from 1 liter of bacterial culture and its purity was 
more than 90 % as jugged by SDS-PAGE (Fig. 2). 
The GST-eEF1Bβ(78–118) deletion form com-
prising the eEF1Bβ leucine-zipper motif was also 
purified by affinity chromatography and additionally 
on a HiLoad 16/600 Superdex 200 per grade column 
(Fig. 2). The yield of the GST-eEF1Bβ(78–118) pro-
tein was estimated to be ~ 4 mg per 1 L of BL21Gold 
bacterial culture. 
Leucine-zipper motif of eEF1Bβ facilitates the 
formation of oligomers
The molecular masses of eEF1Bβ(FL) and its trun-
cated variants were assessed by size-exclusion chro-
matography on a Superose 6 HR column (Fig. 3). 
eEF1Bβ(FL) was eluted from the column as a 
350 kDa protein. This value is about 11 times greater 
than the value of its monomer molecular mass 
(Table 1), strongly suggesting the oligomerization of 
eEF1Bβ(FL). Interestingly, partial or complete dele-
tion of the N-terminal domain only slightly changed 
the elution volume of the proteins: the molecular 
masses of eEF1Bβ(43–281) and eEF1Bβ(78–281) 
were estimated to be 340 and 305 kDa, respectively. 
These results clearly indicate that the N-terminal do-
main of eEF1Bβ may be considered as a distinct 
structural unit that is not involved into oligomeriza-
tion of the full-length protein. Remarkably, deletion 
of the leucine-zipper motif (~5 kDa) causes consid-
erable 5-fold decrease of the protein apparent mo-
lecular mass as estimated by gel filtration. The trun-
cated form eEF1Bβ(117–281), lacking the leucine-
zipper motif, eluted from the column as a 60 kDa 
protein (Fig. 3). Further shortening of the linker re-
gion resulted only in a slight decrease of the 
eEF1Bβ(136–281) molecular mass (58 kDa) com-
pared to eEF1Bβ(117–281). The apparent molecular 
masses of GST-eEF1Bβ(183–281) and GST-
eEF1Bβ(78–118) were estimated to be 175 and 
380 kDa, respectively, suggesting that the self-asso-
ciation of these proteins occurs. 
Recently, the structure of the eEF1Bβ C-terminal 
fragment (residues 153–281), comprising the central 
acidic region and the GEF domain has been report-
ed [11]. The GEF domain of eEF1Bβ has an elon-
gated shape similarly to the GEF domain of the hu-
man and yeast eEF1Bα proteins [22, 23]. The CAR 
domain is folded into loop-α-helix-loop structure 
and is connected to the GEF domain by a flexible 
linker [11, 12]. Thus, the eEF1Bβ C-terminal frag-
ment is a non-globular protein with the extended 
overall shape. This three-fold discrepancy between 
the experimental and theoretical molecular masses 
of the eEF1Bβ(117–281) and eEF1Bβ(136–281) de-
letion mutants may be rationally explained by the 
non-globular nature of both proteins (Table 1). 
The difference between the theoretical and exper-
imentally determined molecular masses of the GST-
Fig. 2. SDS-PAGE of eEF1Bβ(FL) and its truncated forms. The 
indicated proteins (3 µg of each) were loaded onto a 13 % acryl-
amide gel.
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eEF1Bβ(183–281) deletion form (Table 1) may be 
explained not only by an elongated shape of the GEF 
domain but also by homo-dimerization of GST. 
Noteworthy, GST-eEF1Bβ(183–281) is highly ho-
mologous to the GST-eEF1Bα(91–225) truncated 
form, which was shown to behave as a stable dimer 
in solution due to its GST moiety[9]. 
The GST-eEF1Bβ(78–118) fusion protein is com-
posed of the eEF1Bβ leucine-zipper motif (~ 5 kDa) 
and GST (26 kDa). As mentioned above, GST-
Fig. 3. Analysis of eEF1Bβ(FL) and its truncated variants by gel 
filtration: 100 µl of 10 µM eEF1Bβ(FL), eEF1Bβ(43–281), 
eEF1Bβ(77–281), eEF1Bβ(117–281) or eEF1Bβ(136–281), 
17 µM GST-eEF1Bβ(183–281) or 5.3 µM GST-eEF1Bβ (77–
118) were injected into a Superose 6 HR column.
Table 1. Molecular masses of full-length eEF1Bβ and its 
truncated forms
Protein
Molecular mass, kDa
Estimated by  
gel filtration
Theoretical 
(monomer)
eEF1Bβ(FL)
eEF1Bβ(43–281)
eEF1Bβ(78–281)
eEF1Bβ(117–281)
eEF1Bβ(136–281)
GST-eEF1Bβ(183–281)
GST-eEF1Bβ(78–118)
350
340
305
60
58
175
380
31.9
26.9
23.5
19.2
17.3
38.2
31.7
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eEF1Bβ(78–118) was eluted from a Superose 6 HR 
column as a 380 kDa protein (Fig. 3, Table 1). This 
value is more than 11 times greater than the theoreti-
cal value of the GST-eEF1Bβ(78–118) monomer 
(Table 1). Taking into account that GST may dimer-
ize, there is still more than five-fold difference be-
tween the experimental and the theoretical molecu-
lar masses. This result strongly suggests that oligo-
merization of this fusion protein is caused by the 
eEF1Bβ leucine-zipper motif. A leucine-zipper tends 
to fold into the α-helical structure that may self-asso-
ciate to form a coiled coil dimer or oligomer [24]. 
Noticeably, the length of the eEF1Bβ leucine-zipper 
motif is twice that of other leucine-zipper pro-
teins [15]. Consequently, it was hypothesized that 
such a long leucine-zipper motif may form a coiled 
coil trimer structure [25]. Taking into consideration 
possible trimerization capacity of the leucine-zipper 
motif and dimerization of GST, the existence of 
higher order oligomers like the GST-eEF1Bβ(77–118) 
hexamers may be expected. However, additional 
analytical ultracentrifugation experiments are re-
quired to confirm this assumption. 
As mentioned above, the self-association between 
the eEF1Bβ molecules was shown by yeast two-hy-
brid system [13]. However, in the same study the 
N-terminal part of eEF1Bβ including leucine-zipper 
motif (residues 1–150) fused to the GAL4 binding 
domain was not able to sustain the interaction with 
eEF1Bβ(FL) fused to the GAL4 activating domain, 
which contradicts to our results. We believe that the 
absence of the interaction reported in [13] resulted 
from improper folding of the eEF1Bβ N-terminal 
fragment in yeast. In our experiments, similar in 
length N-terminal fragment of eEF1Bβ showed a 
high aggregation propensity (data not shown). 
Hence, deletion of the leucine-zipper motif drasti-
cally decreased the apparent molecular mass of the 
truncated protein compared to full-length eEF1Bβ as 
judged by its elution profile on analytical gel filtra-
tion chromatography. On the other hand, GST fused 
with the leucine-zipper motif was eluted from the 
column as an oligomeric protein similar in size to 
eEF1Bβ(FL) (Table 1, Fig. 3). Thus, the obtained re-
sults favor the notion that the leucine-zipper motif is 
responsible for the eEF1Bβ self-association. 
N-terminally truncated forms of eEF1Bβ dis-
play the catalytic activities similar to that of 
full-length protein
The kinetics of guanine nucleotide exchange on 
eEF1A1 and eEF1A2 in the presence of eEF1Bβ(FL) 
and its truncated forms were measured as described 
previously [9, 21]. As shown in Fig. 4A,B, the par-
tial (42 amino acids) and complete (77 amino acids) 
deletion of the eEF1Bβ N-terminal domain only 
slightly increased (27 %) the rate of GDP/GDP ex-
change on eEF1A2. Further truncation of eEF1Bβ, 
namely deletion of the leucine-zipper motif and the 
part of linker region, did not change the rate of gua-
nine nucleotide exchange, while partial truncation of 
the CAR region resulted in 19 % decrease of the rate 
of guanine nucleotide exchange on eEF1A2. eEF1Bγ 
did not influence the catalytic activity of eEF1Bβ: 
the apparent rate constants of GDP dissociation from 
eEF1A2 catalyzed by eEF1Bβγ complex or eEF1Bβ 
alone were similar. 
Measurements of the rate of GDP/GDP exchange 
on eEF1A1 (Fig. 4C, D) in the presence of the 
eEF1Bβ N-terminally truncated forms, lacking 42, 
77 and 116 amino acids, revealed that their catalytic 
activity is very similar to that of the full-length pro-
tein. In the presence of two other deletion mutants, 
eEF1Bβ(136–281) and GST-eEF1Bβ(183–281), the 
rate of nucleotide exchange decreased by 16 and 
34 %, respectively, as compared to that of the full-
length protein (Fig. 4C, D). Similarly to eEF1A2, 
the rate of GDP dissociation from eEF1A1 in the 
presence of the eEF1Bβγ complex was found to be 
the same as in the presence of eEF1Bβ alone 
(Fig. 4C, D). 
Thus, stepwise truncation of the eEF1Bβ 
N-terminal region including the leucine-zipper motif 
does not significantly affect the catalytic activity of 
the GEF domain. However, partial deletion of the 
central acidic region decreased the rate of guanine 
nucleotide exchange, especially on eEF1A1 (Fig. 4). 
One may expect the CAR domain to be involved in 
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Fig. 4. Guanine nucleotide exchange rates on eEF1A1 and eEF1A2 in the absence and presence of full length eEF1Bβ, its truncated 
forms and the eEF1Bβγ complex. (A, C) First order rate constants of the [3H]GDP/GDP exchange reaction on eEF1A2 (A) and 
eEF1A1 (C) in the absence (k–1) and in the presence (kapp) of indicated exchange factors. The numbers above the bars indicate the 
mean values; the error bars represent standard deviations. (B, D) Time course of the [3H]GDP/GDP exchange reactions on eEF1A2 
(B) and eEF1A1 (D) without or with the indicated exchange factors. The time courses were obtained by averaging two independent 
kinetics experiments; the error bars represent standard deviations. Experimental data (symbols) were fitted to a single exponential 
function (curves). The first order rate constant (k-1) of a spontaneous guanine nucleotide exchange on eEF1A2 was calculated from 
the kinetic curve obtained for the time period of 70 min (data not shown). 
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the interaction with eEF1A, however, steric hin-
drance of the eEF1A binding site by the GST moiety 
in the GST-eEF1Bβ(183–281) fusion protein cannot 
be completely excluded. Further experiments are re-
quired to verify this assumption. 
eEF1Bγ stimulates the guanine nucleotide ex-
change activity of eEF1Bα but not eEF1Bβ [7, 9]. 
Recently, the mechanism for eEF1Bγ-mediated stim-
ulation of eEF1Bα activity has been proposed. The 
N-terminal domain of free full-length eEF1Bα pos-
sesses the conformation that impairs eEF1A binding 
to the GEF domain and in such a way inhibits its 
catalytic activity. The formation of the stable com-
plex between the eEF1Bγ and the eEF1Bα N-terminal 
domains may change the conformation of the latter 
and eliminate this inhibitory effect [9]. The N-terminal 
parts of eEF1Bα and eEF1Bβ are not homologous. 
Unlike eEF1Bα, eEF1Bβ has a leucine-zipper motif 
located in the central part of the molecule between 
the N-terminal and CAR domains (Fig. 1). Here, we 
demonstrated that the leucine-zipper motif mediates 
the self-association of the eEF1Bβ molecules (Fig. 3). 
As mentioned above, a leucine-zipper is usually fold-
ed into the α-helical region that may form the rigid 
coiled coil homo-dimer or homo-oligomer structures 
[24]. In contrast to eEF1Bα, such a rigid conforma-
tion of the eEF1Bβ N-terminal domain most likely 
does not interfere with eEF1A binding to the GEF 
domain. This may explain the reported earlier differ-
ent effects of eEF1Bγ on the eEF1Bα and eEF1Bβ 
catalytic activities [7]. 
Conclusions
The obtained results favor the notion that full-length 
recombinant eEF1Bβ forms stable oligomers in so-
lution and its leucine-zipper motif facilitates this 
oligomerization. As eEF1Bβ most probably belongs 
to a family of non-globular proteins, the exact type 
of its oligomerization will be determined in the fu-
ture analytical ultracentrifugation experiments. 
Deletion of the eEF1Bβ N-terminal domain does 
not significantly affect the guanine nucleotide ex-
change reaction catalyzed by the GEF domain, ex-
cept for the case when the part of the CAR domain 
was removed. The inhibition of the GDP/GDP ex-
change rate after partial deletion of CAR suggests 
that this region might be involved into eEF1A bind-
ing to the catalytic domain. This assumption may be 
a topic for future studies.
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Структурний мотив типу «лейцинова застібка» 
відповідає за асоціацію молекул фактора елонгації 
трансляції 1Bβ
Т. В. Бондарчук, В. Ф. Шалак, Б. С. Негруцький, 
Г. В. Єльська
Фактор елонгації трансляції 1Bβ (eEF1Bβ) – це білок, наявний 
лише у багатоклітинних організмів. Він каталізує обмін гуані-
нових нуклеотидів на факторі елонгації трансляції 1A (eEF1A). 
Відомо, що eEF1Bβ утворює олігомери. Мета. Визначити 
структурний домен eEF1Bβ людини, який опосередковує його 
олігомеризацію. Для встановлення ймовірного впливу 
N-кінцевої ділянки eEF1Bβ на каталітичну активність цього 
білка, було перевірено здатність різних вкорочених форм 
eEF1Bβ каталізувати обмін гуанінових нуклеотидів на обох 
ізоформах eEF1A ссавців. Методи. Фрагменти кДНК, які коду-
ють вкорочені форми, eEF1Bβ отримували шляхом ПЛР амплі-
фікації, потім клонували у відповідні вектори, які експресува-
ли в клітинах Escherichia coli. Рекомбінантні білки очищали і 
їхні молекулярні маси визначали аналітичною гель-
фільтрацією. Активність вкорочених форм eEF1Bβ перевіряли 
в реакції обміну гуанінових нуклеотидів. Результати. 
Видалення N-кінцевого домену eEF1Bβ не вплинуло на його 
олігомерізацію, в той час як видалення мотиву типу «лейцино-
ва застібка» значно зменшувало молекулярну масу вкороченої 
форми білка в порівнянні з повнорозмірною. Також, амінокис-
лотний мотив eEF1Bβ типу «лейцинова застібка» злитий з глу-
татіон S-трансферазою спричиняв олігомерізацію цього хи-
мерного білка. Показано, що всі вкорочені з N-кінця форми 
eEF1Bβ проявляли каталітичну активність, подібну до повно-
розмірного білка. Інгібіторний ефект на каталітичну актив-
ність спостерігався лише для вкороченої форми білка, в якої 
була відсутня частина центрального негативно зарядженого 
регіону. Висновки. Амінокислотний мотив типу «лейцинова 
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застібка» сприяє олігомерізації рекомбінантного eEF1Bβ. 
Поступове вкорочення N-кінцевого домену не має значного 
впливу на каталітичну активність eEF1Bβ. 
К л юч ов і  с л ов а: фактор елонгації трансляції 1, обмін гуа-
нінових нуклеотидів, структурні домени білків.
Структурный мотив типа «лейциновая застёжка» 
отвечает за ассоциацию молекул фактора элонгации 
трансляции 1Bβ.
Т. В. Бондарчук, В. Ф. Шалак, Б. С. Негруцкий,  
А. В. Ельская
Фактор элонгации трансляции 1Bβ (eEF1Bβ) – белок, присут-
ствующий только в многоклеточных организмах. Он катализи-
рует обмен гуаниновых нуклеотидов на факторе элонгации 
трансляции 1A (eEF1A). Известно, что eEF1Bβ образует олиго-
меры. Цель. Определить структурный домен eEF1Bβ челове-
ка, который вызывает его олигомеризацию. Для исследования 
возможного влияния N-концевого участка eEF1Bβ на катали-
тическую активность этого белка, мы проверили способность 
различных укороченных форм eEF1Bβ катализировать обмен 
гуаниновых нуклеотидов на обеих изоформах eEF1A млекопи-
тающих. Методы. Фрагменты кДНК, кодирующие укорочен-
ные формы eEF1Bβ, получали при помощи ПЦР амплифика-
ции, потом клонировали в соответствующие вектора, которые 
экспрессировали в клетках Escherichia coli. Рекомбинантные 
белки очищали и их молекулярные массы определяли аналити-
ческой гель-фильтрацией. Активность укороченных форм 
eEF1Bβ проверяли в реакции обмена гуаниновых нуклеоти-
дов. Результаты. Полное удаление N-концевого домена не 
влияло на олигомеризацию eEF1Bβ, однако удаление мотива 
типа «лейцинова застёжка» значительно уменьшало молеку-
лярную массу укороченной формы белка по сравнению с пол-
норазмерной. Также, присоединение аминокислотного мотива 
eEF1Bβ типа «лейциновая застёжка» к глутатион S-трансферазе 
вызвало олигомеризацию этого химерного белка. Показано, 
что все укороченные с N-конца формы eEF1Bβ проявляли та-
кую же каталитическую активность, как и полноразмерный 
белок. Слабый ингибирующий эффект на каталитическую ак-
тивность наблюдался лишь для укороченной формы белка с 
отсутствующей частью центрального негативно заряженного 
региона. Выводы. Аминокислотный мотив типа «лейциновая 
застёжка» способствует олигомеризации рекомбинантного 
eEF1Bβ. Постепенное укорочение N-концевого домена не ока-
зывает значительного влияния на каталитическую активность 
eEF1Bβ.
К л юч е в ы е  с л ов а: фактор элонгации трансляции 1, об-
мен гуаниновых нуклеотидов, структурные домены белков.
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